Importance Adding a sodium-glucose cotransporter-2 inhibitor (SGLT2-I) to standard-of-care
treatment in patients with heart failure with preserved ejection fraction (HFpEF) reduces the …

Heart failure is highly prevalent with more than 50% of cases being patients with a
preserved ejection fraction (HFPEF), a figure that is projected to increase due to the …

There are almost 1 million people diagnosed with heart failure in the UK, and this number
continues to rise. It is a common cause of hospitalisation and costs associated with those …

Since the implementation of the Hospital Readmissions Reduction Program (HRRP),
readmissions have declined for Medicare patients with conditions targeted by the policy …

Background Heart failure (HF) is a condition that affects approximately 6.2 million people in
the United States and has a 5-year mortality rate of approximately 42%. With the prevalence …

Background Readmissions following exacerbations of chronic obstructive pulmonary
disease (COPD) are prevalent and costly. Multimorbidity is common in COPD and …

Background Heart failure (HF) is associated with a high rate of readmissions within 30 days
post-discharge and in the following year, especially in frail elderly patients. Biomarker data …

Background Registries show international variations in the characteristics and outcome of
patients with heart failure (HF), but national samples are rarely large, and case selection …

Background Heart failure (HF) is a global problem, affecting more than 26 million people
worldwide. This study evaluated the performance of 10 machine learning (ML) algorithms …

Obstructive Sleep Apnea (OSA) increases the risk of diastolic dysfunction and heart failure.
The impact of OSA on hospitalization for heart failure with preserved ejection fraction …